Post-transcriptional mechanisms have the potential to influence complex changes in gene expression, yet their role in cell fate transitions remains largely unexplored. Here, we show that suppression of the RNA helicase DDX6 endows human and mouse primed embryonic stem cells (ESCs) with a differentiation-resistant, ''hyper-pluripotent'' state, which readily reprograms to a naive state resembling the preimplantation embryo. We further demonstrate that DDX6 plays a key role in adult progenitors where it controls the balance between self-renewal and differentiation in a context-dependent manner. Mechanistically, DDX6 mediates the translational suppression of target mRNAs in P-bodies. Upon loss of DDX6 activity, P-bodies dissolve and release mRNAs encoding fate-instructive transcription and chromatin factors that re-enter the ribosome pool. Increased translation of these targets impacts cell fate by rewiring the enhancer, heterochromatin, and DNA methylation landscapes of undifferentiated cell types. Collectively, our data establish a link between P-body homeostasis, chromatin organization, and stem cell potency.
In Brief P-bodies are cytoplasmic RNP granules whose role in stem cells remains largely elusive. Di Stefano et al. show that the disruption of P-bodies upon loss of DDX6 perturbs the self-renewal and differentiation of various stem cell populations through translational upregulation of cell fate regulators and profound rewiring of chromatin landscapes.
INTRODUCTION
Pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), serve as valuable in vitro systems to study stem cell self-renewal and cell fate commitment (Apostolou and Hochedlinger, 2013; Weinberger et al., 2016; Wu and Izpisua Belmonte, 2016) . Differentiation of PSCs requires exit from the pluripotent state, which involves the dissolution of the transcriptional network that maintains self-renewal and the induction of gene expression programs that drive lineage specification during early development (Kalkan and Smith, 2014; Martello and Smith, 2014; Smith, 2017) . A significant body of work in mouse ESCs has established the powerful role of transcription factors (TFs) and chromatin regulators in these processes (Betschinger et al., 2013; Cirera-Salinas et al., 2017; Kalkan et al., 2019; Leeb et al., 2014; Martello et al., 2012; Tian et al., 2019; Waghray et al., 2015; Wray et al., 2011) . However, the mechanisms by which these factors are regulated during exit from pluripotency and their potential role across other stem cell types and species are understudied.
Post-transcriptional control of gene expression is mediated by noncoding RNAs (Flynn and Chang, 2014; Greve et al., 2013) and RNA binding proteins (RBPs) (Guallar and Wang, 2014; Ye and Blelloch, 2014) , which influence gene expression at multiple levels of RNA processing, including splicing, alternative polyadenylation, cellular localization, stability, and translation (Brumbaugh et al., 2018; Keene, 2007; Ye and Blelloch, 2014) . The biological function of RBPs has been predominantly studied in non-mammalian cells or cancer cell lines, even though RBPs are widely expressed across tissues and cell types where they are thought to play critical roles. Previous reports examining RBPs in mouse ESCs focused on regulators of alternative splicing, polyadenylation, and RNA modifications (Batista et al., 2014; Bertero et al., 2018; Brumbaugh et al., 2018; Conway et al., 2016; Geula et al., 2015; Guallar et al., processes such as RNA decay, storage, and translational control remain largely unexplored. Thus, there is a need to define the role of additional, ubiquitously expressed RBPs and associated mechanisms in the context of human pluripotent as well non-pluripotent stem cell populations.
In addition to individual RBPs, processing-bodies (P-bodies) have been implicated in the control of post-transcriptional processes. P-bodies are membrane-less cytoplasmic organelles that form via phase-separation once RNAs and nearby RBPs assemble into ribonucleoprotein particle (RNP) granules (Boeynaems et al., 2018; Luo et al., 2018; Standart and Weil, 2018) . While earlier studies suggested that P-bodies function in both the decay and translational repression of mRNAs, subsequent evidence supported the conclusion that P-bodies primarily control the storage of untranslated mRNAs by sequestering them from the translational machinery (Brengues et al., 2005; Decker and Parker, 2012) . Consistent with the latter notion, mRNAs stored in P-bodies were recently shown to re-enter the ribosome pool in response to changing cellular conditions (Hubstenberger et al., 2017) . These results emphasize the importance of P-bodies in post-transcriptional gene regulation in non-mammalian cells and cancer cell lines. However, their potential function in developmental transitions remains unclear.
In this study, we discovered that the RNA helicase DDX6, which is essential for eukaryotic P-body assembly, is a critical regulator of human and mouse stem cell potency. Mechanistically, DDX6 influences cell fate in a context-dependent manner by controlling the translation of specific mRNAs via P-body assembly. The affected transcripts encode fate-instructive transcription and chromatin factors. Our results further reveal a connection between P-body homeostasis and chromatin organization, which underlie the observed cell fate changes across different lineages.
RESULTS

Exit from Pluripotency Is Initiated by a Posttranscriptional Mechanism
It remains unclear whether exit from pluripotency is initiated by epigenetic, transcriptional, or post-transcriptional mechanisms. To address this question, we compared changes to chromatin accessibility by assay for transposase-accessible chromatin using sequencing (ATAC-seq) and pluripotency transcript levels by qRT-PCR upon treatment of human embryonic stem cells (hESCs) with the transforming growth factor b (TGF-b)-pathway inhibitor A8301 (TGF-bi), which triggers exit from pluripotency. We used ATAC-seq as a proxy for TF activity because changes in TF binding typically underlie changes in chromatin accessibility. After 48 h of TGF-bi treatment, the transcriptional downregulation of key pluripotency genes, including NANOG, OCT4 (POU5F1), and PRDM14 was evident ( Figure S1A ). By contrast, we did not observe significant changes to chromatin accessibility at regulatory regions for these and other pluripotency genes ( Figure S1B ), suggesting that the initial dissolution of the pluripotency circuitry is not due to altered TF binding at stem cell-associated loci. We therefore hypothesized that other, post-transcriptional factors could be key molecular determinants of early stem cell differentiation by modulating the expression of pluripotency genes.
To identify post-transcriptional regulators that may control exit from pluripotency, we analyzed previous loss-of-function screens conducted in mouse and human ESCs. These screens were designed to identify factors that are essential for PSC differentiation (Betschinger et al., 2013; Gonzales et al., 2015; Leeb et al., 2014; Li et al., 2018; Yang et al., 2012) , and the vast majority of reported hits remain unexplored. We first focused on a comprehensive exit from pluripotency screen in hESCs (Gonzales et al., 2015) by searching for RBPs whose suppression confers resistance to differentiation induced with either of two potent commitment stimuli, TGF-bi treatment or withdrawal of the self-renewal factors basic fibroblast growth factor (bFGF) and TGF-b. Intriguingly, small interfering RNAs (siRNAs) targeting DDX6 emerged as the strongest and most consistent suppressor of exit from pluripotency across multiple replicates and conditions ( Figure S1C ). Ddx6 hairpins also scored highly in two similar screens in mouse (Li et al., 2018; Yang et al., 2012) , suggesting that DDX6's role in ESC differentiation is conserved across species ( Figure S1D ). DDX6 encodes an RNA helicase, which is expressed in most human tissues ( Figure S1E ) and has been implicated in the assembly and maintenance of P-bodies based on previous studies in yeast and cancer cell lines (Decker and Parker, 2012; Luo et al., 2018; Parker and Sheth, 2007) . However, its role in pluripotent cells remains unexplored.
DDX6 Is Required for Exit from the Pluripotent State
To investigate the functional role of DDX6 in hPSCs, we utilized a transgenic CRISPR interference (CRISPRi) system in human induced pluripotent stem cells (hiPSCs) (Mandegar et al., 2016 ) that facilitates efficient and temporal transcriptional silencing of DDX6 (Figures 1A and S1F) . We found that all DDX6-specific single guide RNAs (sgRNAs) were highly effective at gene suppression (>70%), with sgDDX6 #5 being the most effective ($90%) ( Figures 1A, 1B , S1G, and S1H). Notably, DDX6 silencing completely abrogated P-body assembly in hPSCs based on staining for the P-body marker EDC4, confirming a previous report in HeLa cells (Ayache et al., 2015) and extending this observation to human PSCs ( Figure 1C ). We then induced differentiation of sgDDX6 and control cells before measuring NANOG expression by flow cytometry and immunofluorescence. While control cells rapidly downregulated NANOG levels, sgDDX6 hiPSCs maintained its expression, consistent with resistance to differentiation ( Figures 1D, 1E , and S1I). In addition, DDX6 suppression impaired the downregulation of other pluripotency-related transcripts such as OCT4, KLF4, and DPPA3 after induction of differentiation ( Figure S1J ). To corroborate these results using an independent cell line and method, we transduced hESCs carrying an OCT4-GFP reporter (Hockemeyer et al., 2011) with lentiviral vectors expressing small hairpin RNAs (shRNAs) against DDX6 (shDDX6 #1 and #2) ( Figure S2A ). Similar to our observation in CRISPRi hiPSCs, shRNA-mediated DDX6 depletion in hESCs impaired downregulation of the OCT4-GFP reporter, NANOG protein, and additional pluripotency-associated transcripts after TGF-bi treatment or withdrawal of bFGF and TGF-b ( Figures S2B-S2D ). Taken together, these data demonstrate that DDX6 is crucial for exit from pluripotency in human PSCs.
We next asked whether our observations in human PSCs were conserved in mouse ESCs (mESCs). For this purpose, we used a reporter line in which a destabilized version of GFP has been knocked into the endogenous Rex1 (Zfp42) locus (termed Rex1-GFP), which is rapidly silenced upon pluripotency exit (Wray et al., 2011) . Similar to our findings in hPSCs, we determined that Ddx6 suppression delayed silencing of the Rex1-GFP reporter and led to sustained expression of pluripotency genes in differentiation conditions (Figures S2E and S2F) .
Collectively, our results show that DDX6 is a key factor controlling the dissolution of the pluripotent state in mouse and human PSCs. 
DDX6 Suppression Facilitates Acquisition of a ''Hyper-Pluripotent'' State in PSCs
To gain insight into the mechanisms by which DDX6 modulates exit from pluripotency, we performed RNA sequencing (RNAseq) to compare gene expression patterns between control and DDX6-depleted hPSCs cultured under self-renewal or differentiation conditions. Remarkably, DDX6 silencing caused widespread transcriptional changes in both self-renewal (2,572 genes upregulated; 2,191 genes downregulated) and differentiation (2,733 genes upregulated; 1,869 genes downregulated) conditions ( Figures 1F and S3A ). As expected, genes upregulated in control cells treated with TGF-bi belonged to differentiationrelated gene ontology (GO) categories ( Figure S3B ). By contrast, genes upregulated in DDX6-depleted cells cultured in selfrenewal or differentiation conditions were associated with categories related to pluripotency such us ''embryo development,'' ''stem cell pluripotency,'' and ''TGF-b signaling,'' consistent with the observed resistance to differentiation . In agreement, genes downregulated after DDX6 suppression in self-renewal or differentiation conditions were associated with categories related to lineage specification including ''cell adhesion,'' ''cell differentiation,'' and ''neurogenesis'' ( Figures S3F-S3I ). Hierarchical clustering of our RNA-seq samples showed that TGF-bi-treated cells depleted for DDX6 were more similar to undifferentiated control samples than to TGF-bi-treated control samples ( Figure 1H ), supporting the notion that suppression of DDX6 retains an undifferentiated transcriptional program. Closer inspection of our RNA-seq data generated from undifferentiated DDX6-depleted cells cultured in self-renewal conditions revealed a marked upregulation of TFs, chromatin regulators and long non-coding RNAs (lncRNAs) associated with pluripotency including OCT4, NANOG, KLF4/5, DPPA2/ 3/4, PRDM14, . We confirmed increased transcript levels for these genes using qRT-PCR ( Figures S1J and S2D ). Similar to our findings in human PSCs, knockdown of Ddx6 in mESCs led to elevated expression of pluripotency TFs ( Figure S2F ), indicating that Ddx6's function in undifferentiated PSCs is again conserved across species.
Together, these data suggest that suppression of DDX6 facilitates the acquisition of a ''hyper-pluripotent'' state that is resistant to differentiation stimuli.
Suppression of DDX6 Endows hPSCs with Naive-like Characteristics Human PSCs cultured in conventional media exist in a primed state that is representative of the post-implantation epiblast, whereas hPSCs exposed to specific pathway inhibitors adopt a naive state that is representative of the pre-implantation epiblast (Weinberger et al., 2016) . Unexpectedly, we discovered that DDX6 suppression not only led to the upregulation of pluripotency genes that are already expressed in primed hESCs but also to the induction of certain genes and pathways associated with naive hPSCs (e.g., KLF4, DPPA3, GDF3) (Figures 1I, 2A, . Accordingly, DDX6 is expressed at lower levels in preimplantation epiblast and naive hESCs relative to post-implantation epiblast and primed hESCs, respectively ( Figures 2B and 2C) , supporting a possible regulatory role for DDX6 during the transition from naive to primed pluripotency.
We therefore investigated whether depletion of DDX6 induces other features associated with naive pluripotency such as DNA hypomethylation and reactivation of the HERVK family of transposable elements. Indeed, our RNA-seq data revealed a significant upregulation of HERVK elements in DDX6-depleted cells while most of the other transposable elements remained unaffected ( Figure 2D ). Reduced representation bisulfite sequencing (RRBS) indicated that although DDX6 depletion did not induce global hypomethylation typical of naive hPSCs, localized demethylation occurred at $200 promoters relative to control cells ( Figure 2E ). Further analysis of these hypomethylated regions revealed that several of these sites corresponded to promoters of known naive-specific genes, including DPPA2, DPPA3, and PIWIL2 ( Figure 2E ), which are activated after DDX6 suppression ( Figure 1I ).
To assess the transcriptional similarity between DDX6-depleted hESCs and bona fide naive hESCs globally, we reprogrammed primed hESCs to a naive state using the 5i/LAF condition (Theunissen et al., 2014 ) and compared their transcriptome to that of shCTRL-and shDDX6-transduced primed hESCs. Indeed, principal component analysis (PCA) of these samples suggests that suppression of DDX6 endows hESCs cultured in conventional conditions with a state that is between primed and bona fide naive pluripotent cells ( Figure 2F ). Suppression of DDX6 also facilitated the reprogramming of primed hESCs to a bona fide naive state in 5i/LAF media, which is based on increased induction of the naive-specific DPE OCT4-GFP reporter ($70% GFP + cells in shDDX6 cells versus 20% GFP + cells in control) (Theunissen et al., 2014) and elevated levels of the naive markers DPPA5, ZFP42, DPPA3, and KLF4 ( Figures 2G and 2H ). Similar to our observations in human primed cells, mouse EpiSCs depleted for Ddx6 upregulated the naive-associated genes Klf4 and Dppa3 and reprogramed into a Rex1-GFP + naive state at higher efficiency compared to control cells (Figures S4A-S4C) .
Together, these data indicate that DDX6 suppression in primed hESCs and mouse EpiSCs induces transcriptional and epigenetic features associated with naive pluripotency, which facilitate reprogramming to a bona fide naive state in the presence of appropriate signals.
DDX6 Controls Adult Stem/Progenitor Cell Potency in a Context-Dependent Manner
To investigate if DDX6 can influence self-renewal and differentiation of non-pluripotent stem cells, we initially suppressed DDX6 expression in hiPSC-derived neural progenitor cells (NPCs) and analyzed global gene expression changes by RNA-seq. We did not detect changes in the expression of the progenitor cell genes SOX2 and NESTIN in DDX6-depleted NPCs ( Figure 3A) , while SOX1 was slightly downregulated ($1.5-fold) ( Figure S4D ). However, DDX6 suppression led to the downregulation of lowly expressed transcripts involved in neuronal differentiation and maturation, and the upregulation of regulators of cell proliferation ( Figures 3A, S4E , and S4F), suggesting that DDX6 keeps NPCs in a poised, differentiation-competent state. Indeed, DDX6 suppression strongly impaired the formation of bIII-tubulin + neurons ( Figures 3B   and 3C ), a finding confirmed with CRISPRi NPCs ( Figures  S4G-S4K ). Thus, similar to the phenotype we observed in hPSCs, DDX6 appears to be essential for the differentiation of NPCs into neurons. Next, we determined the possible roles of DDX6 within the endodermal lineage by studying mouse intestinal stem cells (ISCs). Briefly, we derived organoid cultures from Lgr5-GFP mice (Tian et al., 2011) and infected them with lentiviruses carrying shRNAs targeting the mouse Ddx6 gene ( Figure 3D ). Ddx6 depletion did not result in obvious morphological changes of organoids ( Figure 3E ) yet led to a greater than 2-fold increase in the number of Lgr5 + ISCs ( Figure 3F ), suggesting that suppression of Ddx6 facilitates the maintenance or expansion of the intestinal stem cell pool. Finally, we tested the effect of DDX6 depletion on mesodermal progenitor identity by studying the differentiation of myoblasts into myotubes. Surprisingly, DDX6 knockdown dramatically increased rather than blocked the formation of MyHC + multinucleated myotubes by up to 10-fold after 4 days of differentiation . RNA-seq revealed that thousands of genes were aberrantly expressed in myoblasts depleted for DDX6 (1,366 genes upregulated; 1,040 genes downregulated) ( Figure 3K ). While upregulated genes were associated with categories related to cell differentiation, downregulated genes were involved in cellcycle progression ( Figure 3L ). For example, myogenin (MYOG), which is a strong inducer of differentiation, was readily induced in myoblasts after DDX6 depletion in self-renewal conditions, consistent with precocious differentiation ( Figure 3M ). Given the unexpected myoblast result, we asked whether DDX6 opposes differentiation in other mesoderm-associated (B) Single-cell RNA-seq data for DDX6 expression in human preimplantation embryos (Petropoulos et al., 2016) . EPI, epiblast; PE, primitive endoderm; TE, trophectoderm. (C) RNA-seq and protein expression data for DDX6 in primed and naive hESCs (Di Stefano et al., 2018) . For RNA-seq data, n = 5, mean ± SD, unpaired Student's t test, ***p < 0.001. For proteomic data, n = 3, mean ± SD, unpaired Student's t test, **p < 0.01. (legend continued on next page) stem cells by utilizing human mesenchymal stem cells (MSCs).
To this end, we derived MSCs from hiPSCs ( Figures S4L-S4O ) and induced chondrogenic differentiation ( Figure 3N ). Similar to our findings in myoblasts, suppression of DDX6 in MSCs enhanced chondrocyte differentiation based on the elevated expression of chondrocyte markers ( Figure 3O ). These comprehensive analyses indicate that DDX6 affects the differentiation potential of somatic progenitors in a context-specific manner.
DDX6 Interacts with Crucial P-Body Proteins, which Control Stem Cell Potency To understand the mechanisms by which DDX6 controls cell fate and the possible involvement of P-bodies, we determined its binding partners in hiPSCs by performing immunoprecipitation for DDX6, followed by mass spectrometry (IP-MS) (Figures 4A and 4B; Table S1 ). Notably, of the 127 proteins identified in hiPSCs, 78 were previously found in HEK293T cells as DDX6 interaction partners, suggesting that a large fraction of proteins associated with DDX6 (61%) are shared across cell types (Figure S5A ; Ayache et al., 2015) . Moreover, GO analysis based on all detected DDX6-associated proteins showed a strong enrichment for categories linked to RNA binding and RNP granules, consistent with DDX6's role in P-body maintenance ( Figures  4C and 4D ). For example, our analysis revealed interactions between DDX6 and members of the decapping complex (DCP1A and DCP1B), PABPC1 and PABPC4, and the LSM family of proteins, all of which have been implicated in P-body biology (Luo et al., 2018; Figures 4E and S5B) . Given that DDX6 silencing in hiPSCs leads to a loss of P-bodies ( Figure 1C ), we next asked whether DDX6 loss affects the stability of P-body-enriched DDX6 interactors. To this end, we performed large-scale quantitative proteomic analysis of sgCTRL and sgDDX6 hiPSCs (Figure S5C) , identifying 6,868 proteins (Table S2 ). Analysis of these data revealed that many DDX6-interacting proteins (e.g., LSM14A, LASM14B, DCP1A) were significantly downregulated after DDX6 depletion ( Figure 4F ), a finding confirmed by western blot and immunofluorescence analyses ( Figures S5D-S5G ). Critically, transcripts encoding these DDX6-interacting proteins were not affected by DDX6 suppression ( Figure S5H ). These results show that DDX6 interacts with several key P-body components in stem cells, which are post-transcriptionally downregulated with loss of DDX6.
If disruption of P-bodies is indeed critical for the phenotypes observed with DDX6 loss, we would expect that suppression of other factors essential for the maintenance of P-bodies would phenocopy these results while suppression of non-essential P-body components should have no effect on cell fate. To test this possibility, we depleted LSM14A and DCP1A in hESCs and induced exit from pluripotency. Similar to the sgDDX6 phenotype, knockdown of LSM14A, which is essential for P-bodies (Ayache et al., 2015) , resisted pluripotency exit (Figures 4G, S5I, and S5J) . By contrast, knockdown of DCP1A, which does not affect P-body maintenance (Ayache et al., 2015) , had no effect on pluripotency exit (Figures 4G, S5I, and S5J) .
Collectively, these data reinforce the notion that DDX6 and LSM14A, two genes crucial for P-bodies, are functionally required for hPSC differentiation.
DDX6's Helicase Activity Is Essential for P-Body Assembly and Pluripotency Exit DDX6's highly conserved DEAD domain was previously shown to have helicase activity in vitro (Sloan and Bohnsack, 2018) . To test whether this enzymatic function is required for P-body assembly, we used lentivirus to express either a wild-type (DDX6 WT) or a catalytically inactive point mutant (DDX6 EQ) (Jangra et al., 2010) in our transgenic CRISPRi hiPSCs (Figures 4H, S5K, and S5L) . Of note, expression of DDX6 WT successfully rescued DDX6 expression and restored the assembly of EDC4 + P-bodies in these hiPSCs ( Figure 4I ). By contrast, hiPSCs expressing the DDX6 EQ mutant were unable to restore P-bodies ( Figure 4I ), indicating that the intrinsic helicase activity of DDX6 is essential for P-body formation in pluripotent cells, extending previous observations in cancer cell lines (Jangra et al., 2010) .
To test whether DDX6's helicase activity is also necessary for pluripotency exit, we treated our CRISPRi hiPSCs transduced with either DDX6 WT or DDX6 EQ lentiviral vectors with TGF-bi and monitored the expression of NANOG by immunofluorescence. Similar to sgCTRL cells, DDX6-depleted cells infected with the DDX6 WT vector readily differentiated as reflected by efficient downregulation of NANOG expression ( Figure 4J ). Strikingly, however, expression of the DDX6 EQ mutant failed to downregulate NANOG expression, indicating that the intrinsic helicase activity of DDX6 is also essential for hPSC differentiation ( Figure 4J ). Supporting these observations, DDX6 EQ infected CRISPRi cells expressed higher levels of pluripotency genes such as KLF4, NANOG, PRDM14 and DPPA3 in self-renewal and differentiation conditions compared to sgCTRL or DDX6 WT-infected sgDDX6 cells (Figures 4K and 4L) . Of note, sgCTRL cells transduced with the DDX6 EQ mutant also upregulated the pluripotency markers DPPA3 and KLF4 and showed a subtle delay in pluripotency exit, suggesting that this helicase mutant may function as a dominant-negative allele in WT cells ( Figure S5M ), consistent with previous observations (Jangra et al., 2010) .
Finally, we exploited our CRISPRi system to assess whether reactivation of the endogenous DDX6 locus would reverse the aberrant hyper-pluripotent state and rescue the loss of P-bodies. To this end, we suppressed DDX6 with dox for 7 days followed by dox withdrawal for another 7 days before measuring pluripotency transcripts and P-body assembly. We readily detected P-bodies and the concomitant downregulation of pluripotency transcripts upon re-expression of DDX6 ( Figures 4M and 4N ), suggesting that P-body re-assembly indeed facilitates reversion from the hyper-pluripotent to the primed state.
Taken together, these results demonstrate that DDX6 mediates P-body assembly through its helicase activity and further strengthen our conclusion that P-body assembly is required for pluripotency exit.
DDX6 Overexpression Increases P-body Number and Accelerates Exit from Pluripotency
To determine whether DDX6 is sufficient to modulate pluripotency exit and P-body assembly, we transduced hPSCs with a lentiviral overexpression vector for DDX6 and measured P-body assembly and pluripotency exit. Indeed, DDX6 overexpression (DDX6 OE) led to a significant increase in cytoplasmic EDC4 + P-bodies under self-renewal conditions ( Figure 5A ).
Moreover, DDX6 OE led to a 3-fold decrease in the percentage of OCT4-GFP + hESCs under differentiation conditions, suggesting enhanced differentiation ( Figure 5B ). RNA-seq analysis revealed that DDX6 OE caused widespread transcriptional changes in both self-renewal (upregulated genes n = 607; downregulated genes n = 750) and differentiation (upregulated genes n = 654; downregulated genes n = 510) conditions (Figures 5C and 5D) . Genes upregulated in DDX6 OE cells were associated with GO categories related to cell differentiation, consistent with the observed acceleration of differentiation ( Figures S6A-S6C ). Accordingly, we observed downregulation of TFs, chromatin regulators and lncRNAs associated with pluripotency in DDX6 OE cells, including KLF4, NANOG, UTF1, and LINC-ROR ( Figures 5C and 5D ).
These data demonstrate that forced DDX6 expression is sufficient to induce P-bodies and promote hPSC differentiation.
DDX6-Bound mRNAs Are Translationally Suppressed in P-Bodies
To understand how P-body assembly and disassembly via DDX6 may modulate cell fate, we identified DDX6 mRNA targets by carrying out enhanced UV crosslinking and immunoprecipitation (eCLIP)-seq (Van Nostrand et al., 2016b) in hiPSCs ( Figure 5E ). We observed good correlation among biological replicates (Pearson correlation coefficient r = 0.88) ( Figure S6D ) and found that DDX6 binding patterns are not biased toward highly expressed RNA targets, supporting the quality and specificity of our datasets ( Figure S6E ). Overall analysis of DDX6 binding patterns revealed a preferential association with coding regions over introns (Figures 5F and S6F) , which is in line with previous reports (Sloan and Bohnsack, 2018) . Notably, DDX6 mRNA targets included factors involved in chromatin organization, transcription, RNA processing, and stem cell regulation ( Figure 5G ). For example, we found mRNAs encoding key pluripotency TFs (e.g., OCT4, NANOG) and chromatin regulators, including several histone demethylases, histone deacetylase complexes (e.g., NURD), and H3K4 methylases among DDX6 targets in hiPSCs (Table S3 ). In addition, many DDX6-bound mRNAs were previously shown to be physically present in P-bodies in 293T cells ( Figure 5H ; Hubstenberger et al., 2017) , suggesting that a large fraction of DDX6-bound mRNAs are localized inside P-bodies across different cell types.
To test whether DDX6 perturbation affects gene expression and cell fate by influencing the stability of mRNA targets, we blocked transcription initiation in our CRISPRi hiPSCs using Actinomycin D and measured pluripotency mRNA levels. Unexpectedly, DDX6 depletion did not alter mRNA decay rates of the pluripotency regulators KLF4, NANOG, POU5F1, SOX2, PRDM14, and TFAP2C ( Figure S6G ), suggesting that DDX6 does not affect mRNA stability in hiPSCs.
We next explored the hypothesis that DDX6 affects the translation of mRNA targets in pluripotent cells by sequencing total and polysomal RNAs following DDX6 depletion. We failed to detect obvious differences in polysome profiles when comparing DDX6-depleted and control cells, suggesting that DDX6 is not a global repressor of translation ( Figure 5I ). However, we observed a significant increase in translational efficiency (p = 6.77 3 10 À58 ) when considering only those mRNAs that are directly targeted by DDX6 and physically associated with P-bodies ( Figures 5J and S6H) . Notably, these transcripts were strongly enriched for AU-rich sequences ( Figure S6I ), which have previously been associated with translational repression by DDX6 (Qi et al., 2012) . Moreover, we detected key TFs and chromatin regulators with association to pluripotency among this group of mRNAs, including ZIC3, MSL2, (N) QRT-PCR analysis of selected pluripotency genes. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, unpaired Student's t test. n = 3, mean ± SD. See also Figure S5 and Tables S1 and S2. MBLN1, and PTEN ( Figures 5K, 5L , S6J, and S6K). Of note, MBLN1 and PTEN protein levels were also higher in naive hESCs relative to primed cells (Figures S6J and S6K) and likely contributed to the efficient reprogramming of DDX6-depleted cells into a naive state ( Figure 2G ). DDX6 and P-bodies have also been implicated in microRNA (miRNA)-mediated suppression of RNA translation (Chan and Slack, 2006; Freimer et al., 2018; Kulkarni et al., 2010) , suggesting that relief from miRNA-mediated silencing may be another mechanism by which DDX6 suppression affects stem cell potency. In support of this idea, we found that some mRNA targets that changed translation in DDX6 knockdown cells were enriched for binding sites of miRNAs ( Figure S6L ) previously implicated in pluripotency control and reprogramming (Leonardo et al., 2012) .
Together, these data strongly suggest that mRNAs encoding for transcription factors and chromatin complexes are targeted by DDX6 in P-bodies to maintain them in a translationally repressed state.
Disrupting P-Bodies Impacts Chromatin Organization in Diverse Developmental Contexts
The observation that DDX6 regulates the translation of multiple TFs and chromatin regulators raises the key question of See also Figure S6 and Table S3. whether P-body disassembly alters the chromatin organization of pluripotent cells. To test this hypothesis, we determined chromatin accessibility by ATAC-seq analysis in hiPSCs depleted for DDX6 for 6 days. Notably, hiPSCs exhibited an overall increase in accessible chromatin regions following DDX6 suppression relative to controls (7,420 sites with increased accessibility; 3,999 sites with decreased accessibility) ( Figure 6A ). TF motif analysis revealed an enrichment for pluripotency TFs such as ZIC3, TFAP2C, and KLF4/5 ( Figure 6B ), which concurs with our observation that these TFs were upregulated at the RNA and/ or protein level in DDX6-depleted iPSCs ( Figure 1I ; Table S2 ).
To determine whether regions with differential chromatin accessibility are enriched for specific functional elements, we next performed chromatin immunoprecipitation sequencing (ChIPseq) for relevant modifications including the enhancer mark H3K27ac, the proximal promoter mark H3K4me3, and the heterochromatic mark H3K9me3. We observed extensive remodeling at enhancers upon DDX6 suppression, as reflected by 3,528 regions that gained H3K27ac compared to only 712 regions that lost it ( Figures 6C-6E ). Additionally, pluripotency-specific superenhancers were significantly more acetylated in DDX6-depleted cells relative to control, suggesting that DDX6 loss impacts different types of enhancers ( Figure 6D ). Importantly, key pluripotency regulators such as GDF3, DPPA4, UTF1, KLF17, and OCT4 (POU5F1) were among the enhancers that gained H3K27ac, consistent with increased chromatin accessibility for these regions as observed in our ATAC-seq analysis (Figure 6E) . We also detected a dramatic redistribution of H3K9me3 in DDX6-depleted cells relative to control cells (1,494 sites lost; 1,279 sites gained) ( Figure 6F ). For example, DDX6 depletion led to reduced H3K9me3 levels at regulatory regions of several ZFP and ZSCAN factors (see ZSCAN2 example in Figure 6E ). In contrast to H3K27ac and H3K9me3 patterns, H3K4 trimethylation remained largely unaffected in sgDDX6 hiPSCs (142 sites gained; 85 sites lost) ( Figure S7A ). These results indicate that DDX6 silencing causes major epigenetic remodeling at enhancers and heterochromatic regions while promoters and TSSs remain largely unaffected. In order to test whether our observations extend to adult progenitor cell populations, we measured chromatin accessibility in human myoblasts depleted for DDX6 for 4 days. Indeed, similar to hiPSCs, myoblasts exhibited an overall increase in chromatin accessibility at enhancer regions following DDX6 silencing relative to controls ( Figures 6G, 6H , and S7B). Consistent with the increased differentiation we observed in in DDX6-depleted myoblasts, more accessible regions were enriched for TFs and growth factors associated with myogenic differentiation ( Figure 6G ). In addition, motif analysis of these regions revealed an enrichment for TFs implicated in muscle differentiation ( Figure 6I ).
Taken together, our results show that suppression of DDX6 modulates the chromatin organization of human PSCs and myoblasts, which in turn may underlie the specific cell fate changes we observed across different developmental contexts.
Regulation of KDM4B Contributes to the ContextDependent Phenotypes of DDX6 Depletion
To further strengthen the connection between P-body homeostasis, chromatin organization, and cellular plasticity, we finally searched for DDX6 targets involved in chromatin remodeling that are common across cell types. To this end, we performed eCLIP-seq in undifferentiated myoblasts ( Figure S7C ; Table S4 ) and compared data with our hiPSC eCLIP dataset. Of note, $55% of our DDX6 targets were shared between human iPSCs and myoblasts (Figures S7D and S7E) . Among the common DDX6 targets, H3K9 demethylases emerged as an intriguing class of proteins as they have previously been implicated in stem cell potency in different contexts (Cloos et al., 2008) , and we detected a widespread change of H3K9me3 in DDX6-depleted hiPSCs ( Figure 6F ). Specifically, we focused on the H3K9 demethylase KDM4B since it exhibited an increased translational rate in sgDDX6 cells ( Figure 6J ) and consequently was upregulated at the protein level without affecting mRNA levels in human iPSCs and myoblasts following DDX6 knockdown ( Figures 6K and S7F-S7I ). In addition, KDM4B overexpression reportedly enhances MSC differentiation toward chondrocytes (Lee et al., 2016) , which is consistent with the observed effect of DDX6 suppression in MSCs ( Figures 3N and  3O ). To examine whether this phenotypic link between KDM4B and DDX6 modulation in MSCs extends to other progenitor cell populations, we depleted KDM4B in human muscle progenitors. Considering that DDX6 depletion facilitates muscle differentiation, we predicted that KDM4B depletion would block differentiation. Indeed, suppression of KDM4B in human myoblasts led to a significant decrease in the number of differentiated myotubes as judged by reduced MYH1 expression ( Figures  6L and 6M) .
We next explored whether the effects of KDM4B and DDX6 modulation are also correlated in pluripotent cells. In mESCs, Kdm4b is involved in the regulation of stem cell-associated gene expression and occupies active pluripotency-specific enhancers (Das et al., 2014) , again consistent with an opposing effect to DDX6. Thus, we transduced hESCs with a retroviral KDM4B overexpression vector (Castellini et al., 2017) and measured OCT4-GFP expression following withdrawal of bFGF and TGF-b or treatment with TGF-bi. Indeed, KDM4B overexpression significantly increased the percentage of OCT4-GFP + hESCs in both conditions ( Figures 6N and S7J ). In addition, KDM4B overexpressing hESCs cultured in these conditions showed higher expression of the pluripotency markers NANOG, POU5F1, DPPA3, KLF4, and ZIC3 compared to control cells ( Figure S7K ), paralleling the effect of DDX6 suppression.
Collectively, these data uncover KDM4B as a common and functionally relevant target of DDX6 across different cell fate transitions.
DISCUSSION
Here, we demonstrated a crucial role for the RNA helicase DDX6 in cell fate control ( Figure 7A ). DDX6-mediated gene regulation is required for exiting the pluripotent state and for proper differentiation. Conversely, DDX6 suppression is sufficient to drive both mouse and human ESCs to a more primitive state, consistent with its role in the maintenance of pluripotent cell states. Our study also provides comprehensive evidence that DDX6 controls the potency of a variety of adult progenitor cell types across the three germ layers, thus extending its role to a more general regulator of cell fate. While our data suggest ChIP-seq data for sgDDX6 #5 (n = 2) and sgCTRL (n = 2) hiPSCs. Red dots indicate genomic regions with significantly decreased H3K27ac signal in DDX6-depleted cells (>2-fold change; n = 712); green dots indicate genomic regions with significantly increased H3K27ac signal in DDX6-depleted cells (2-fold change; n = 3,528). (D) H3K27ac signal at pluripotency-specific super-enhancers (n = 684) in sgCTRL (n = 2) and sgDDX6 (n = 2) hiPSCs. Statistical significance was determined using a Student's t test. (E) Gene tracks of individual genes based on RNA-seq, ChIP-seq, and ATAC-seq data.
(legend continued on next page) that DDX6 drives exit from self-renewal toward a differentiated state in some adult progenitors akin to its role in hPSCs (i.e., NPCs and endoderm progenitors), it seems to maintain the self-renewal and inhibit differentiation in others (i.e., mesenchymal and muscle progenitors).
Based on our proteomic data in hPSCs and the available literature, we surmise that DDX6 acts as a hub for other translational repressors and mRNA decay enzymes, orchestrating the assembly of P-bodies. Our results further suggest that DDX6 coordinates the reversible storage in P-bodies of untranslated transcripts encoding key cell fate regulators, including transcription and chromatin factors ( Figure 7B ). Once P-bodies are disassembled, either through DDX6 downregulation or mutation of its helicase activity, mRNAs are released and available to the translational machinery. Increased protein levels of encoded transcription and chromatin factors then potently influence cell fate by remodeling the enhancer and heterochromatin landscapes of embryonic and adult stem cells. Based on these observations, we propose that P-body assembly confers a ''poised'' state on stem cells, which may quickly be reversed upon reception (F) Scatterplot showing H3K9me3 ChIP-seq data for sgCTRL (n = 2) and sgDDX6 #5 (n = 2) hiPSCs. Red dots indicate genomic regions showing significantly decreased H3K9me3 coverage in DDX6-depleted cells (>2-fold change; n = 1,494); green dots indicate genomic regions with significantly increased H3K9me3 signal in DDX6-depleted cells (2-fold change; n = 1,279). (G) Scatterplot showing correlation of ATAC-seq data for shCTRL-(n = 2) and shDDX6-infected (n = 2) human myoblasts. Blue dots indicate genomic regions with significantly decreased chromatin accessibility in DDX6-depleted cells (>1.5-fold change, p < 0.001; n = 1,099); red dots indicate genomic regions with significantly increased chromatin accessibility in DDX6-depleted cells (1.5-fold change, p < 0.001; n = 1,864). See also Figure S7 and Table S4 . of appropriate cues, thus facilitating development and differentiation in a timely manner and endowing cells with a certain degree of developmental plasticity.
Our results reveal that disrupting P-bodies in PSCs and adult progenitors elicits a remarkably rapid response for H3K27 acetylation at enhancers. Considering the profound changes in H3K27ac levels we detected in DDX6-depleted cells, it is noteworthy that the chromatin landscape at promoters was largely unaffected by DDX6 loss. Another unexpected observation is the rapid redistribution of the H3K9me3 mark at heterochromatic regions in hPSCs depleted for DDX6 (Figure 7B ). During development, histone acetylation controls enhancer dynamics in stem cells (Perino and Veenstra, 2016) , while compacted heterochromatin expands as cells mature, assisting in the establishment and maintenance of cell identity (Zhu et al., 2013) . Indeed, modulation of histone acetylation and depletion of H3K9me3 facilitate TF-induced cell fate changes, somatic cell nuclear transfer and the acquisition of a naive pluripotent state (Becker et al., 2016; Chung et al., 2015; Federation et al., 2014; Matoba et al., 2014; Theunissen et al., 2016) . Thus, these chromatin changes may underlie the context-specific effects on cell fate we observed in distinct lineages and the establishment of the hyper-pluripotent and naive-like state in DDX6-depleted hPSCs ( Figure 7A ).
We could assign at least some of the cell-type-specific effects of DDX6 suppression to dysregulation of the H3K9 demethylase KDM4B, which is a common DDX6 target across different cell types and is upregulated at the protein level in DDX6-depleted cells. However, the biological consequences of DDX6 depletion in any given progenitor cell population is likely more complex and involves additional chromatin factors besides KDM4B as well as cell-type-specific TFs. Consistent with this interpretation, we observed increased expression of the lincRNA Linc-ROR after DDX6 silencing in hPSCs. Linc-ROR is required for exit from the pluripotent state (Loewer et al., 2010; Wang et al., 2013) as well as for osteogenic differentiation of MSCs (Feng et al., 2018) . The context dependency we observed for DDX6 in progenitor cells may also help to explain previous, seemingly opposing observations in mouse neural cells and human keratinocytes lacking DDX6 (Nicklas et al., 2015; Wang et al., 2015) .
Recently, Freimer et al. (2018) reported intriguing similarities in translational regulation between Ddx6-deficient mESCs and Dgcr8-deficient mESC, which lack all miRNAs. This observation, together with our finding that some DDX6 targets in hPSCs harbor miRNA recognition sequences, suggests that the effect of DDX6 on cellular potency may be partially explained by its role in miRNA-mediated translational repression. It is further important to mention that DDX6 is not exclusively localized to P-bodies, but reportedly interacts with other RBPs in the cytoplasm (Ayache et al., 2015) . It is therefore also possible that non-P-body dependent functions of DDX6 contribute to some of the phenotypes we observed in our study.
In summary, by interrogating DDX6's role in human PSCs and adult stem and progenitor cells, we have uncovered a previously unrecognized role for P-bodies in stabilizing cell identity by modulating the storage of mRNAs encoding for key cell fateinstructive proteins. In addition to providing important insight into the role of post-transcriptional mechanisms in cell fate control, our findings have a bearing on potential therapeutic applications, as modulation of DDX6 could be exploited to expand clinically relevant stem cell populations.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: and incubated for an additional 24 hours before FACS analysis for OCT4-GFP or NANOG expression. DDX6 silencing in the CRISPRi cells was achieved by supplementing the medium with 2 mg/ml doxycycline (Sigma). For the doxycycline washout experiment, sgDDX6 #5 hiPSCs were cultured in mTeSR1 Medium supplemented with 2 mg/ml doxycycline (Sigma) for 1 week, followed by doxycycline withdraw for an additional week.
STAR+METHODS KEY RESOURCES TABLE
To achieve reversion to a naive state, female WIBR3 (''DPE-OCT4-GFP) hESCs (Theunissen et al., 2014) that had been passaged 6 days earlier were washed once with 1X PBS (Life Technologies) and treated for 3 minutes with TrypLE express enzyme (1X, Life Technologies). Cell were dissociated into a single-cell suspension and plated at a density of 30,000 cells per 9.5cm 2 on irradiated CF-1 MEFs (GLOBALSTEM INC, Pooled male and female) in hESC medium supplemented with 10 mM Y-27632 (Axon Medchem). Two days later, medium was changed to 5i/LAF and then changed daily. 5i/LAF medium contained a 50:50 mixture of DMEM/ F-12 (Life Technologies) and Neurobasal medium (Life Technologies) containing 1x N2 supplement (Life Technologies), 1x B27 supplement (Life Technologies), 10 ng/mL bFGF (Peprotech), 1% nonessential amino acids (Life Technologies), 1mM GlutaMAX (Life Technologies), penicillin-streptomycin (Life Technologies), 0.1 mM b-mercaptoethanol (Life Technologies), 50 mg/mL BSA (Life Technologies), 0.5 mM IM-12 (Axon Medchem), 0.5 mM SB590885 (Axon Medchem), 1 mM WH-4-023 (Axon Medchem), 10 mM Y-27632 (Axon Medchem), 20 ng/mL Activin A (Peprotech), 20 ng/mL rhLIF (Peprotech), 0.5% KSR (Life Technologies) and 1 mM PD0325901 (Axon Medchem). After roughly 8-10 days, cells were dissociated using Accutase (Life Technologies) and centrifuged in fibroblast medium [DMEM (Life Technologies) supplemented with 10% FBS (Hyclone), 1 mM GlutaMAX (Life Technologies), 1% nonessential amino acids (Life Technologies), penicillin-streptomycin (Life Technologies), 0.1 mM b-mercaptoethanol (Life Technologies)] and replated after passing through a 40 mm cell strainer in 5i/LAF medium on irradiated CF-1 MEFs. Established naïve hESC lines were cultured on irradiated CF-1 MEFs (2.5x10 6 cells per 9.5 cm 2 ) in 5i/LAF medium and passaged every 6-7 days. Cells were fed daily with fresh medium. Naïve hESCs were cultured under low oxygen conditions (5% O 2 ) at 37 C.
Human mesenchymal stem cell culture and chondrocyte differentiation Human mesenchymal stem cells (male) were derived from CRISPRi hiPSCs using the STEMdiff Mesenchymal Progenitor Kit (Stem Cell Technologies) following the manufacturer's instructions. Differentiation of mesenchymal stem cells into chondrocytes was achieved using the MesenCult-ACF Chondrogenic Differentiation Medium (Stem cell technologies).
Human myoblasts culture
Primary human skeletal myoblasts (pooled male and female cells) were obtained from Thermo Fisher (GIBCO, A12555) and cultured at 37 C in MegaCell DMEM (Sigma) containing 5% FBS (Lonza), 2 mM glutamine (Life Technologies), 0.1mM b-mercaptoethanol (Life Technologies), 1X MEM non essential Amino Acids Solution (Life Technologies), 5 ng/ml bFGF (Peprotech), Penicillin (100 U/mL), Streptomycin (100 mg/mL).
Human neural progenitor cell culture and neuronal differentiation Human neural progenitor cells derived from xcl-1 pluripotent stem cells (male) were obtained from Stem Cell Technologies (cat# 70901) and cultured in neural progenitor medium 2 (Stem Cell Technologies, cat# 08560) at 37 C. Differentiation into neurons was achieved using the STEMdiff Neuron Differentiation Kit (Stem Cell Technologies, cat# 08500).
For NPC induction from CRISPRi cells (male), hiPSCs were cultured in DMEM/F12 medium (Life Technologies) supplemented with 1X N2 supplement (Life Technologies), 2 mM glutamine (Life Technologies), 100 nM LDN-193189 (Stemgent, 04-0074) , 10 mM SB431542 (Tocris, 1254) and 2 mM XAV939 (Stemgent, 04-00046). After 9 days, cells were passaged on Matrigel (Corning) coated dishes using Accutase (Life Technologies) and maintained in STEMdiff Neural Progenitor Medium (Stem Cell Technologies). Neuronal differentiation was achieved by culturing NPCs on Matrigel coated dishes in Neurobasal medium supplemented with 1X B27 (Life Technologies), 10 ng/ml BDNF (Peprotech), 10 ng/ml GDNG (Peprotech), ascorbic acid (50 mg/ml, Sigma), 5 mM Forskolin (Sigma).
Mouse embryonic stem cell culture Mouse ESCs ''Rex1-GFP'' (Rex1::GFPd2 129/sv, male) (Wray et al., 2011) were cultured at 37 C in naive mESC culture medium consisting of DMEM/F12 medium and Neurobasal medium (1:1 ratio), supplemented with MEM non essential Amino Acid Solution (1X), Sodium Pyruvate (1mM), L-Glutamine (2mM), Penicillin (100 U/mL), Streptomycin (100 mg/mL), b-mercaptoethanol (50 mM), N2 and B27 supplements, two small-molecule inhibitors PD0325901 (1 mM, Axon Medchem) and CHIR99021 (3 mM, Axon Medchem), and ESGROÒ Leukemia Inhibitory Factor (LIF) (1000 U/mL, EMD Millipore).
Induction of exit from pluripotency was performed essentially as described (Betschinger et al., 2013) . Briefly, 6-well plates were coated with 0.1% (W/V) EmbryoMaxÒ gelatin at 37 C for 5 minutes. Rex1GFPd2 cells were disassociated with Accutase (Life Technologies) for 2 minutes at room temperature then washed twice with PBS, and 2X10 5 cells were seeded in each well with naive mESC culture medium without the two inhibitors and LIF.
Mouse epiblast stem cell derivation and culture For EpiSC derivation, embryos were harvested on day E6.5, according to the protocol described in Chenoweth and Tesar (2010) . Briefly, egg cylinder stage embryo was cut at the embryonic/extraembryonic boundary, the embryonic fragment was incubated in dissociation medium (0.5% trypsin and 2.5% pancreatin w/v in PBS) for 5 min on ice, transferred to Embryomax FHM HEPES -buffered medium (EMD Millipore) for 5 min, and drawn through a hand-pulled glass pipette to remove the visceral endoderm. Epiblasts were initially plated on CF-1 MEFs (pooled female and male cells) in EpiSC media at 37 C, and after 1-3 days dissociated with Accutase (ThermoFisher) and passaged onto Fibronectin-coated plates in EpiSC maintenance medium with the addition of 10mM Y-27632 ROCK inhibitor (Axon Medchem). TetO-Nanog/M2-rtTA EpiSC were generated by deriving EpiSC from timed mating between Rex1-GFP females (C57BL/6 3 129S4/SvJae mixed background), gift of Pentao Liu) and TetO-Nanog/M2-rtTA males (C57BL/6 3 129S4/SvJae mixed background) (Palla et al., 2015) . Rex1-GFP/TetO-Nanog/M2-rtTA EpiSCs (male) were maintained on fibronectin (EMD Millipore) coated dishes in EpiSC medium (DMEM/F12 (Life Technologies) with N2 (1:200) and B27 (1:100) supplements (Life Technology), 1X Glutamax (Life Technologies), MEM Non-Essential Amino Acids Solution (1X), 100mM b-mercaptoethanol (Life Technologies), 50 mg/ml bovine serum albumin (BSA; Life Technologies), supplemented with recombinant human Activin A (20 ng/ml; Peprotech) and bFGF (12 ng/ml; Peprotech). EpiSCs were passaged as clumps of 5-20 cells by incubating with Accutase (Life Technology), and plated at a split ratio of 1:3 to 1:8 every 1-2 days. EpiSC lines were used between passage numbers 10-20 for all experiments described.
For conversion of EpiSCs into naive ESCs, cells were dissociated with Accutase for 15 minutes to achieve single cell suspension, and seeded on 6-well plates on MEFs (5x10 5 cells/well) at a density of 5x10 3 cells/well, in EpiSC media containing Activin A (20 ng/ml; Peprotech), bFGF (12 ng/ml; Peprotech), 10mM Y-27632 ROCK inhibitor (Axon Medchem) in the presence of 2 mg/ml doxycycline to activate the Nanog transgene. After 24 hours, media was switched to reprogramming conditions for 7 days: KO-DMEM (ThermoFisher) supplemented with 15% Knockout Serum Replacement (Life Technologies), with N2 (1:100) and B27 (1:100) supplement (Life Technologies), 1X Glutamax (Life Technologies), 100 mM MEM non-essential amino acids (Life Technology), 100mM b-mercaptoethanol (Life Technologies), 500 mg/ml bovine serum albumin (BSA; Life Technologies), 10 3 IU LIF, 1 mM PD0325901 (Axon Medchem), and 3 mM CHIR99021 (Axon Medchem). Reprogramming to the naive state was assessed by flow cytometric analysis for the Rex1-GFP reporter.
HEK293T culture HEK293T (human, female) were obtained from ATCC (Cat# CRL3216) and cultured at 37 C in DMEM medium (Life Technologies) supplemented with FBS (Life Technologies), 1X Glutamax (Life Technologies), 100 mM MEM non-essential amino acids (Life Technologies), Penicillin (100 U/mL) (Life Technologies), Streptomycin (100 mg/mL) (Life Technologies).
Mouse intestinal organoid culture
Crypt isolation and organoid culture (from 3 months old female Lgr5tm2(DTR/EGFP)Fjs C57BL/6NCrl mice) were performed as previously described (Sato et al., 2009) . Organoid lines were infected with shRNA lentiviral vectors as previously described (Koo et al., 2013) . Once infected, organoids were selected for 7 days with 1 mg/mL puromycin (Invivogen).
METHOD DETAILS
Western blot analysis and IP Cells were dissociated using Trypsin-EDTA (Thermo-Fisher Scientific) and collected by centrifugation at 350 RCF for 5 minutes in media containing DMEM (Life Technologies), 10% Fetal Bovine Serum (Hyclone), 1X Non-essential Amino Acids (Life Technologies), 1X Glutamax (Life Technologies). The cells were then washed twice in ice-cold PBS (Life Technologies) and pelleted at 350 RCF for 5 minutes. Ten million cells were then incubated on ice for 5 minutes in 100 ml of nuclear isolation buffer (50 mM Tris$HCl (pH 8.0), 60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 1 mM CaCl 2 , 250 mM sucrose, 1 mM DTT, 0.6% IGEPAL (all from Sigma-Aldrich), complete mini protease inhibitors (Roche Diagnostics) and PhosSTOP phosphatase inhibitors (Roche Diagnostics). Nuclei were pelleted at 960 RCF and the supernatant containing the cytoplasmic fraction was collected for further analysis. The resulting nuclear pellet was washed twice in nuclear isolation buffer and lysed in RIPA buffer (50 mM Tris-HCL (pH8), 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 1 mM EDTA (all from Sigma-Aldrich), complete mini protease inhibitors (Roche Diagnostics), and PhosSTOP phosphatase inhibitors (Roche Diagnostics). Both nuclear and cytoplasmic fractions were sonicated for 5 minutes in a Bioruptor bath sonicator (Diagenode).
For immunoprecipitation, cell lysates were separated from cell debris via centrifugation at 18,000 RCF for 5 minutes at 4 C. To preclear the lysates, 30 ul of Protein G Mag Sepharose beads (GE Healthcare) were equilibrated for 5 minutes in RIPA buffer and added to the lysates, which were then incubated at 4 C with rotation for one hour. In total, 6 mg of either DDX6 antibody (Novus Biologicals) or rabbit IgG control (AbCam) were added per 100 mL of pre-cleared lysate. The lysates were then incubated overnight at 4 C with rotation. The next day, 50 ul of equilibrated Protein G Mag Sepharose beads were added to each lysate and incubated for one hour at 4 C with rotation. The beads were then washed twice in RIPA buffer and an additional three times in 50 mM Tris-HCl (pH 8), 150 mM NaCl, 0.2 mM EDTA (all from Sigma-Aldrich) complete mini protease inhibitors (Roche Diagnostics), and PhosSTOP phosphatase inhibitors (Roche Diagnostics). The beads were then taken for further analysis by mass spectrometry.
In preparation for western blot analysis, cell fractions were generated as described above. The following antibodies were used for western blot: bIII-TUBULIN ( 
Vectors and cloning
The pLKO-shDDX6 #1 (TRCN0000074696) and pLKO-shDDX6 #2 (TRCN0000074694) vectors targeting the human DDX6 genes were obtained from the Molecular Profiling Laboratory of the MGH Cancer Center. The shERWOOD UltramiR Lentiviral shRNAs targeting the mouse Ddx6 gene were purchased from Transomic technologies. The shERWOOD UltramiR Lentiviral shRNAs targeting the human KDM4B gene were purchased from Transomic Technologies. The pLKO-shDCP1A (TRCN0000235901) and pLKOshLSM14A (TRCN0000128028) vectors were obtained from the Molecular Profiling Laboratory of the MGH Cancer Center. For CRISPRi, five gRNAs were designed to target regions near the transcription start site (TSS) of the gene of interest (250 bp upstream and downstream, respectively). The location of the TSS was determined using the UCSC genome browser (https://genome.ucsc. edu). sgRNA oligos were designed, phosphorylated, annealed and cloned into the pgRNA-CKB vector using BsmBI ligation strategy as previously described (Mandegar et al., 2016) . The following sgRNAs were tested for DDX6 silencing:
#1 CGCCGCGGCGAATATAGCCG (-strand); #2 TGGCGAAACCTCGGCCGCCG (+strand); #3 GCGGTCGCCGCCATGCGGAG (-strand); #4 TTCGGCGGCGCCACGAGAGC (-strand); #5 CAGCCAGGCGGCGACTTCGG (-strand).
Lentiviral vectors expressing the wild-type and mutant (E247Q) DDX6 cDNAs were obtained from Vector Builder. The PCLP-KDM4B and PCLP-empty vectors were described earlier (Castellini et al., 2017) .
Virus production
Virus production was performed as previously described (Di Stefano et al., 2014) . Briefly, HEK293T cells were co-transfected with vector plasmid and packaging plasmids using the TransITÒ-293 Transfection Reagent (Mirus). Viral supernatants were collected 32 hours later and concentrated by ultracentrifugation at 20,000g for 2 h at 20 C. Viral concentrates were re-suspended in PBS and stored at À80 C.
sgRNA nucleofection and selection of stable CRISPRi lines
The sgRNA-expression vector (pgRNA-CKB) was transfected into the CRISPRi cells with the human stem cell nucleofector kit 1 solution on the Amaxa nucleofector 2b device (program A-23; Lonza). Two million CRISPRi hiPSCs and 5 mg of the circular sgRNAexpression plasmid were used per nucleofection. Nucleofected cells were then seeded in a single well of a 6-well plate in mTeSR1 supplemented with Y-27632 (10 mM). Blasticidin selection (10 mg/ml) was applied 24 h post-nucleofection in mTeSR1 supplemented with Y-27632 (10 mM) for 7-10 days, until stable colonies appeared. Stable colonies were then pooled and passaged at least three times in mTeSR1 plus Blasticidin and Y-27632 and FACS sorted for mKATE2 expression to enrich for cells with integration at transcriptionally active sites.
RNA preparation RNA isolation was performed using the miRNeasy mini kit (QIAGEN). RNA was eluted from the columns using RNase-free water and quantified using a Nanodrop ND-1000. cDNA was produced with the High Capacity RNA-to-cDNA kit (Applied Biosystems). TaqMan-based qRT-PCR reactions were set up using the TaqMan Universal Master Mix II, no-UNG (Life Technologies,1 3 5 mL (4440040)) and the following TaqMan probes (from Life Technologies): TaqManÒ Gene Expression Assays (DDX6) Hs00898915_g1 size XS 75rnx (4448892); TaqManÒ Gene Expression Assays (ACTB) (SIZE: S 250 RNX) Hs99999903_m1 (4453320); TaqManÒ Gene Expression Assays (HPRT1) Hs02800695_m1 (4453320).
qRT-PCR analyses
Measurement of RNA stability Cells were treated with Actinomycin D (Tocris) (10 mg/ml) for 0, 0.5, 1.5, 2.5, 4 and 5 hours to determine the half-life of target mRNAs. RNA was isolated from the samples and qRT-PCR was used to determine the levels of target genes. RPS18 was used as control gene for data normalization.
DNA preparation DNA was extracted using the DNeasy Blood & Tissue Kit (QIAGEN) and quantified using the Qubit dsDNA High Sensitivity Kit (Life Technologies). reduction and alkylation as detailed above. Proteins were digested first with 1 ug LysC at room temperature overnight and then 500 ng trypsin at 37 C for 7 hours. Digests were acidified and cleaned via StageTip prior to TMT labeling (5 ml), pooling, and desalting as described above.
The pooled TMT-labeled peptides from whole-cell lysates were fractionated using BPRP HPLC using an Agilent 1260 Infinity pump equipped with a degasser and a single wavelength detector (set at 220 nm). Peptide separation occurred over an Agilent 300Extend C18 column (3.5 mm particles, 4.6 mm ID and 250 mm in length) across a 50 min linear gradient from 8% to 40% acetonitrile in 10 mM ammonium bicarbonate, pH 8 at a flow rate of 0.6 ml/min. A total of 96 fractions were collected and then consolidated into 24 and vacuum centrifuged to dryness. Twelve of the 24 fractions were resuspended in a 5% acetonitrile, 1% formic acid solution. Fractions were desalted via StageTip, dried via vacuum centrifugation, and reconstituted in 5% acetonitrile, 5% formic acid for LC-MS/MS processing.
Mass spectrometry data were collected using an Orbitrap Fusion Lumos mass spectrometer (Thermo Fischer Scientific) equipped with a Proxeon EASY-nLC 1000 liquid chromatography (LC) system (Thermo Fisher Scientific). Peptides were separated on a 100 mm inner diameter microcapillary column packed with $35 cm of Accucore C18 resin (2.6 mm, 150 Å , Thermo Fisher Scientific). Approximately 2ug peptides were separated using a 2.5 h gradient of acidic acetonitrile. The multinotch MS3-based TMT method was used . The scan sequence began with a MS1 spectrum (Orbitrap analysis; resolution 120,000; mass range 400À1400 Th). MS2 analysis followed collision-induced dissociation (CID, CE = 35) with a maximum ion injection time of 120 ms and an isolation window of 0.7 Th. The 10 most abundant MS1 ions of charge states 2-5 were selected for MS2/MS3 analysis. To obtain quantitative information, MS3 precursors were fragmented by high-energy collision-induced dissociation (HCD, CE = 65) and analyzed in the Orbitrap (resolution was 50,000 at 200 Th) with a maximum ion injection time of 150 ms and a charge state-dependent variable isolation window of 0.7 to 1.2 Da (Paulo et al., 2016) .
Enhanced Crosslinking and Immunoprecipitation (eCLIP) eCLIP (Van Nostrand et al., 2016b) was performed for DDX6 using CRISPRi hiPSCs and human myoblasts. 2 3 10 7 cells for each replicate were UV-crosslinked (254 nm, 400 mJ/cm 2 ), collected and lysed. Lysates were sonicated, subjected to limited RNase I digestion (40 U per ml of lysate) and RNA-protein complexes immunoprecipitated for 16 h at 4 C with 10 mg affinity-purified antibody (DDX6 #A300-460A, Bethyl). Prior to immunoprecipitation, an aliquot of each extract was removed and stored at 4 C for preparation of the size-matched input (SMInput) control. Complexes were collected with anti-mouse or rabbit magnetic beads, washed, dephosphorylated and 3 0 -ligated on-bead to custom oligonucleotides. All samples (IPs and SMInputs) were run on 4%-12% polyacrylamide gradient gels and complexes transferred to nitrocellulose membranes. Successful immunoprecipitation was confirmed by parallel western blotting of fractions of each sample using the antibodies described above. RNA-protein complexes in the range from the RBP apparent molecular mass to 75 kDa above (corresponding to crosslinked RNAs of up to $200 nucleotides in length) were excised from the membrane and RNAs released with proteinase K. SMInput samples were dephosphorylated and 3 0 -ligated. All samples (IPs and SMInputs) were reverse transcribed and cDNAs 5 0 -ligated on-bead, quantified by qPCR, and PCR-amplified with < 18 cycles. PCR products were size-selected to 175-350 bp on agarose gels and resulting libraries sequenced on a HiSeq4000 instrument (Illumina) in paired-end 55 bp mode (eCLIP). All oligonucleotide adapters and primers are described in Van Nostrand et al. (2017 , 2016b .
Polysome profiling
CRISPRi hiPSCs (8 3 10 7 cells for each biological replicate) were treated with 100 mg/ml cycloheximide (CHX, Tocris #0970) for 2 minutes at 37 C. Cell culture plates were then transferred on ice, the cells were scraped in 1X PBS supplemented with 100 mg/ml CHX and collected. After centrifugation, cell pellets were resuspended in 500 ml lysis buffer (20 mM Tris pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 1% Triton X-100, 100 mg/ml CHX, 1 mM DTT, 20 U/ml SUPERase-In (Invitrogen)), centrifuged at 14,000 3 g for 10 min at 4 C and the supernatants were collected and stored at À80 C. Lysates were clarified by centrifugation at 17,500 3 g at 4 C for 15 min. 100 ml lysate was reserved for inputs and 400 ml lysate used for fractionation. For fractionation, a 10%-50% (w/v) sucrose gradient was prepared in polysome buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5mM MgCl 2 , 1 3 protease inhibitor cocktail (EMD Millipore), 100 mg/ml CHX, 1 mM DTT, and 20 U/ml RNase inhibitor (RNaseOUT, Thermo Fisher)). Samples were loaded on the sucrose gradient and centrifuged at 35,000 3 g (Beckman, rotor SW41) at 4 C for 3 h. Fractions were collected from the top and UV absorbance monitored using a Gradient Station (BioCamp) equipped with ECONO UV monitor (BioRad). 500 ml fractions were collected using a FC203B fraction collector (Gilson). Fractions containing monosome, light polysome, medium polysome, heavy polysome, and total polysome were identified by their UV absorbance and pooled. Total RNA from the inputs and each pool were extracted in TRIzol-LS (Thermo Fisher) and purified with Direct-zol RNA kits (Zymo). RNA sequencing libraries were generated and sequenced, and reads processed as described above. Strand-specific RNA sequencing libraries were prepared from 0.5 mg total RNA using the TruSeq Stranded mRNA Sample Preparation kit (Illumina). Libraries were sequenced on the HiSeq 4000 platform in SE75 mode.
Chromatin Immunoprecipitation Sequencing (ChIP-seq) 5 3 10 6 cells were crosslinked with 1% FA for 10 minutes at RT. Glycine was added to a final concentration of 125mM and mixed for 5min at RT. Crosslinked cells were washed with DPBS 2x then spun down 3min at 15000 g. Cells were then incubated with 500mL cell
Cell Stem Cell 25, 1-17.e1-e13, November 7, 2019 e10 using a peptide mass tolerance of 20 ppm, and a fragment ion tolerance of 0.9 Da. These wide-mass-tolerance windows were chosen to maximize sensitivity in conjunction with SEQUEST searches and linear discriminant analysis (Beausoleil et al., 2006; Huttlin et al., 2010) . TMT tags on lysine residues and peptide N termini (+229.163 Da) and carbamidomethylation of cysteine residues (+57.021 Da) were set as static modifications, while oxidation of methionine residues (+15.995 Da) was set as a variable modification. Peptide-spectrum matches (PSMs) were filtered using linear discriminant analysis and adjusted to a 1% false discovery rate (FDR) as described previously (Elias and Gygi, 2007; Huttlin et al., 2010) . Linear discriminant analysis considered the following parameters: XCorr, DCn, missed cleavages, adjusted PPM, peptide length, fraction of ions matched, charge state, and precursor mass accuracy. Peptides were again filtered to a final protein-level FDR of 1%. Peptides were quantified from MS3 scans after filtering out those with poor quality (required total TMT reporter signal-to-noise ratio > 200 and isolation specificity > 0.7). Protein quantitation was performed by summing the signal-to-noise values for all peptides for a given protein, and each TMT channel was summed across all quantified proteins and normalized to enforce equal protein loading. Each protein's quantitative measurements were then scaled to sum to 100 across all samples.
eCLIP-seq analysis For eCLIP-seq data, sequencing reads were processed as described (Van Nostrand et al., 2016a) . Reads were adaptor-trimmed and mapped to human-specific repetitive elements from RepBase (version 18.04) by STAR (Dobin et al., 2013) . Repeat-mapping reads were removed, and remaining reads mapped to the human genome assembly hg19 with STAR. PCR duplicate reads were removed using the unique molecular identifier (UMI) sequences in the 5 0 adaptor and remaining reads retained as 'usable reads'. Peaks were called on the usable reads by CLIPper (Lovci et al., 2013) and assigned to gene regions annotated in Gencode (v19). Each peak was normalized to SMInput by calculating the fraction of the number of usable reads from immunoprecipitation to that of the usable reads from the SMInput. Peaks were deemed significant at R 4-fold enrichment and p value % 10 À3 (Chi-square test, or Fisher's exact test for read numbers in eCLIP or SMInput < 5). For all target gene analyses, genes with at least 1 significant peak binding on transcripts were called target genes. For region analysis, usable reads were assigned to all transcripts annotated in Gencode v19. For reads overlapping > 1 annotated region, each read was assigned to 1 region with the following descending priority order: CDS, 5 0 UTR, 3 0 UTR, intron. For each gene, reads were summed up across each region to calculate final region counts. A pseudocount read was added to sets with 0 reads in the region. Read counts were normalized by the total usable reads for calculating the fold-enrichment between immunoprecipitation over SMInput.
ATAC-seq analysis
For ATAC-seq, sequenced reads were aligned against the hg19 reference genome using BWA (Li and Durbin, 2010) . Alignments were filtered for uniquely mapped none-mitochondrial reads and duplicates were removed. Peak calling was carried out with HOTSPOT (John et al., 2011) . We identified 90,000 -110,000 peaks, which showed high consistency between biological duplicates. The union of these peak sets was used to calculate the ATAC-seq coverage over each peak region across all samples. Differential accessible peaks were identified using edgeR (Robinson et al., 2010) with at least 1.5-fold difference and FDR < 0.01. Sequence motifs for differential accessible peaks were identified with MEME-chip (Bailey et al., 2009 ).
Polysome profiling analysis
For polysome profiling, RNA-seq reads were trimmed using cutadapt (v1.4.0) of adaptor sequences and mapped to repetitive elements (RepBase v18.04) using STAR (v2.4.0i) . Reads that did not map to repetitive elements were then mapped to the human genome (hg19). GENCODE (v19) gene annotations and featureCounts (v.1.5.0) were used to create read count matrices. The transcript RPKMs of inputs and polysome fraction pools were calculated from the read count matrices. Translation ratios were measured by calculating the RPKM ratio of transcript levels in polysome pools over input. Translation ratio fold changes between knockdown samples and their respective controls were calculated and used to calculate cumulative probabilities. Translationally upregulated and downregulated genes were defined as log 2 (translation ratio fold change) > 0.5 fold and < 0.5 fold, respectively. Kvector (https://github.com/olgabot/kvector) was used to count k-mers from the < foreground > bed file of significantly upregulated peaks and < background > bed file containing randomly defined peaks with the same genic distribution as foreground peaks. The enrichment score of each k-mer was calculated by Z-test by using the number of k-mers in the foreground relative to the background. HOMER was used to identify de novo motifs using the command 'findMotifsGenome.pl < foreground > hg19 < output location > -rna -S 20 -len 6 -p 4 -bg < background > ' Foreground was a bed file of translation upregulated peaks; the background was randomly defined peaks within the same annotated region as foreground peaks.
ChIP-seq analysis For ChIP-seq, data processing was done mainly following the Blueprint Chip-Seq analysis pipeline (http://dcc.blueprint-epigenome. eu/#/md/chip_seq_grch37). In brief, single end 75bp reads were aligned against the hg19 human reference genome using bwa mem version 0.7. 17-r1188 (arXiv:1303 ) and duplicates were marked using gatk markduplicates version 4.0.11.0 (http:// broadinstitute.github.io/picard). The aligned data were further filtered for minimum mapping quality of 15. For peak calling first the fragment size was modeled using the PhantomPeakQualTools R script (Kharchenko et al., 2008) .
